Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zy...

FDA Recall #D-0639-2025 — Class II — September 3, 2025

Recall #D-0639-2025 Date: September 3, 2025 Classification: Class II Status: Ongoing

Product Description

Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-051-01

Reason for Recall

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

N/A

Distribution

Nationwide in the USA

Code Information

Lot #: Z305085, Exp Date 30-09-25; Z401166, Z401167, Exp Date 28-02-26

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated